Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for upadacitinib (Rinvoq) for the treatment of giant cell arteritis (GCA) in adults. Upadacitinib is used in combination with corticosteroids and as monotherapy (on its own) following discontinuation of corticosteroids.